Orthotopic implantation mouse model and cDNA microarray analysis indicates several genes potentially involved in lymph node metastasis of colorectal cancer

Cancer Science

Volumn 99, Issue 4, 2008, Pages 711-719

  Sasaki, Hiroyuki ^a   Miura, Koh ^a   Horii, Akira ^a   Kaneko, Naoyuki ^a   Fujibuchi, Wataru ^b   Kiseleva, Larisa ^b   Gu, Zhaodi ^a   Murata, Yukio ^a   Karasawa, Hideaki ^a   Mizoi, Takayuki ^a   Kobayashi, Terutada ^a   Kinouchi, Makoto ^a   Ohnuma, Shinobu ^a   Yazaki, Nobuki ^a   Unno, Michiaki ^c   Sasaki, Iwao ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MATRIGEL; RING FINGER PROTEIN; RING FINGER PROTEIN 125; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 41349109766     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00725.x     Document Type: Article

References (34)

1. Ajiki W, Tsukuma H, Oshima A. Cancer incidence and incidence rates in Japan in 1999: Estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2004; 34: 352-6.
2. Statistics and Information Department Minister's Secretariat, Ministry of Health Labour and Welfare. Vital Statistics in Japan, Trends Up to 2004. Tokyo, Japan: Health and Welfere Statistics Association Publisher, 2006 (in Japanese).
3. Japanese Society for Cancer of the Colon and Rectum. Treatment Guidelines on Cancer of the Colon, Rectum and Anus. Tokyo, Japan: Kanehara Publishers, 2005 (in Japanese).
4. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, Martin GR. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 1982; 21: 6188-93.
5. Yoshida Y, Kamitani N, Sasaki H, Kusumi K, Tominaga T, Kotsuji F. Establishment of a liver metastatic model of human ovarian cancer. Anticancer Res 1998; 18: 327-31.
6. Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL. Reconstituted basement membrane (Matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci USA 1990; 87: 6698-702.
7. Fridman R, Kibbey MC, Royce LS et al. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel. J Natl Cancer Inst 1991; 83: 769-74.
8. Noel A, Simon N, Raus J, Foidart JM. Basement membrane components (Matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen. Biochem Pharmacol 1992; 43: 1263-7.
9. Topley P, Jenkins DC, Jessup EA, Stables JN. Effect of reconstituted basement membrane components on the growth of a panel of human tumour cell lines in nude mice. Br J Cancer 1993; 67: 953-8.
10. Bao L, Matsumura Y, Baban D, Sun Y, Tarin D. Effects of inoculation site and Matrigel on growth and metastasis of human breast cancer cells. Br J Cancer 1994; 70: 228-32.
11. Yue W, Brodie A. MCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitors. J Steroid Biochem Mol Biol 1993; 44: 671-3.
12. Wilson MJ, Sinha AA. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected Matrigel impregnated with human prostate tumor cells. Anat Rec 1997; 249: 63-73.
13. Pretlow TG, Delmoro CM, Dilley GG, Spadafora CG, Pretlow TP. Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res 1991; 51: 3814-17.
14. Tsutsumi S, Kuwano H, Morinaga N, Shimura T, Asao T. Animal model of para-aortic lymph node metastasis. Cancer Lett 2001; 169: 77-85.
15. Takahashi T, Morotomi M, Nomoto K. A novel mouse model of rectal cancer established by orthotopic implantation of colon cancer cells. Cancer Sci 2004; 95: 514-9.
16. Nguyen ST, Hasegawa S, Tsuda H et al. Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma. Cancer Sci 2007; 98: 740-6.
17. Fujiwara K, Ochiai M, Ubagai T et al. Differential gene expression profiles in colon epithelium of two rat strains with distinct susceptibility to colon carcinogenesis after exposure to PhIP in combination with dietary high fat. Cancer Sci 2003; 94: 672-8.
18. Bertucci F, Salas S, Eysteries S et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 2004; 23: 1377-91.
19. Japanese Society for Cancer of the Colon and Rectum. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus, 6th edn. Tokyo, Japan: Kanehara Publishers, 1998 (in Japanese).
20. Quinn LA, Moore GE, Morgan RT, Woods LK. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res 1979; 39: 4914-24.
21. Cespedes MV, Espina C, Garcia-Cabezas MA et al. Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol 2007; 170: 1077-85.
22. Zhao H, Li CC, Pardo J et.al. A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation. J Immunol 2005; 174: 5288-97.
23. Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA 2007; 104: 7500-5.
24. Su ZZ, Sarkar D, Emdad L, Barral PM, Fisher PB. Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression. J Cell Physiol 2007; 213: 502-10.
25. Voutsadakis IA. Pathogenesis of colorectal carcinoma and therapeutic implications: The roles of the ubiquitin-proteasome system and Cox-2. J Cell Mol Med 2007; 11: 252-85.
26. Hempe JM, Cousins RJ. Cysteine-rich intestinal protein binds zinc during transmucosal zinc transport. Proc Natl Acad Sci USA 1991; 88: 9671-4.
27. Monga DK, O'Connell MJ. Surgical adjuvant therapy for colorectal cancer: current approaches and future directions. Ann Surg Oncol 2006; 13: 1021-34.
28. Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ. Adjuvant treatment of colorectal cancer. CA Cancer J Clin 2007; 57: 168-85.
29. Benson AB 3rd, Schrag D, Somerfield MR et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004; 22: 3408-19.
30. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 1999; 17: 1356-63.
31. Wang Y, Jatkoe T, Zhang Y et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 2004; 22: 1564-71.
32. Al-Mulla F, Behbehani AI, Bitar MS, Varadharaj G, Going JJ. Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse. Mod Pathol 2006; 19: 648-58.
33. Kwon HC, Kim SH, Roh MS et al. Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Colon Rectum 2004; 47: 141-52.
34. Frederiksen CM, Knudsen S, Laurberg S, Orntoft TF. Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol 2003; 129: 263-71.